Certified by Founder Lodge
Odimma Therapeutics

START UP
1 Disclosed Funding Rounds $2,213,210
0 Participating Investments
-
Founded date
2017
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Odimma is a French biotech company with a unique approach in active personalized cancer immunotherapy.
Immunotherapy has revolutionized the treatment of many advanced cancers. Despite this